Anti-M üllerian hormone: a novel biomarker for aggressive prostate cancer? Emerging evidence from a prospective study of radical prostatectomies

CONCLUSIONS: Low AMH blood levels were correlated with aggressive prostate cancer in this radical prostatectomy cohort of patients. Therefore, AMH could be a prognostic biomarker for the aggressiveness of the disease.PMID:38127275 | DOI:10.1007/s42000-023-00520-z

Source: Hormones - December 21, 2023 Category: Endocrinology Authors: Stavros Kontogiannis Georgios Markantes Maria Stamou Michail Tsagkarakis Irini Mamali Konstantinos Giannitsas Petros Perimenis Neoklis Georgopoulos Anastasios Athanasopoulos Source Type: research